Fatigue, Cardiovascular Decline, and Events after Breast Cancer Treatment
Main Authors: | Jennifer H. Jordan, PhD, MS, Ralph B. D’Agostino, Jr., PhD, Nancy E. Avis, PhD, Shannon L. Mihalko, PhD, Peter H. Brubaker, PhD, Dalane Kitzman, MD, Karen M. Winkfield, MD, PhD, Cynthia K. Suerkin, MS, Kerryn W. Reding, PhD, MPH, RN, Heidi D. Klepin, MD, MS, Glenn J. Lesser, MD, W. Gregory Hundley, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | JACC. CardioOncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087320300223 |
Similar Items
-
Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis
by: Hideo Wada MD, PhD, et al.
Published: (2020-08-01) -
Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
by: Yoshihide Ueda, MD, PhD, et al.
Published: (2017-12-01) -
Modified Anterolateral Approach for Total Ankle Arthroplasty
by: Makoto Hirao MD, PhD, et al.
Published: (2021-06-01) -
Clinical effect and immunological response in patients with advanced malignant glioma treated with WT1-pulsed dendritic cell-based immunotherapy: A report of two cases
by: Keiichi Sakai, MD, PhD, et al.
Published: (2017-09-01) -
Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities
by: Jens Hemmingsson, MS, et al.
Published: (2018-07-01)